Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.

Vantyghem MC, Chetboun M, Gmyr V, Jannin A, Espiard S, Le Mapihan K, Raverdy V, Delalleau N, Machuron F, Hubert T, Frimat M, Van Belle E, Hazzan M, Pigny P, Noel C, Caiazzo R, Kerr-Conte J, Pattou F.

Diabetes Care. 2019 Oct 15. pii: dc190401. doi: 10.2337/dc19-0401. [Epub ahead of print]

PMID:
31615852
2.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
3.

Is RAGE the receptor for inflammaging?

Frimat M, Teissier T, Boulanger E.

Aging (Albany NY). 2019 Sep 8;11(17):6620-6621. doi: 10.18632/aging.102256. Epub 2019 Sep 8. No abstract available.

4.

Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.

Hamroun A, Lenain R, Bui Nguyen L, Chamley P, Loridant S, Neugebauer Y, Lionet A, Frimat M, Hazzan M.

Sci Rep. 2019 Aug 29;9(1):12508. doi: 10.1038/s41598-019-49036-w.

5.

The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis.

Artru F, Louvet A, Glowacki F, Bellati S, Frimat M, Gomis S, Castel H, Barthelon J, Lassailly G, Dharancy S, Noel C, Hazzan M, Mathurin P.

Aliment Pharmacol Ther. 2019 Jul;50(1):75-83. doi: 10.1111/apt.15279. Epub 2019 May 14.

PMID:
31087566
6.

Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, Pontoizeau C, Cochat P, Bataille P, Bridoux F, Brignon P, Choquenet C, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Frimat M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

BJU Int. 2019 Feb 24. doi: 10.1111/bju.14721. [Epub ahead of print]

PMID:
30801923
7.

Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.

Teissier T, Quersin V, Gnemmi V, Daroux M, Howsam M, Delguste F, Lemoine C, Fradin C, Schmidt AM, Cauffiez C, Brousseau T, Glowacki F, Tessier FJ, Boulanger E, Frimat M.

Aging Cell. 2019 Apr;18(2):e12850. doi: 10.1111/acel.12850. Epub 2019 Feb 22.

8.

Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.

May O, Merle NS, Grunenwald A, Gnemmi V, Leon J, Payet C, Robe-Rybkine T, Paule R, Delguste F, Satchell SC, Mathieson PW, Hazzan M, Boulanger E, Dimitrov JD, Fremeaux-Bacchi V, Frimat M, Roumenina LT.

Front Immunol. 2018 Dec 20;9:3008. doi: 10.3389/fimmu.2018.03008. eCollection 2018.

9.

Endothelium structure and function in kidney health and disease.

Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT.

Nat Rev Nephrol. 2019 Feb;15(2):87-108. doi: 10.1038/s41581-018-0098-z. Review.

PMID:
30607032
10.

Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.

Merle NS, Grunenwald A, Rajaratnam H, Gnemmi V, Frimat M, Figueres ML, Knockaert S, Bouzekri S, Charue D, Noe R, Robe-Rybkine T, Le-Hoang M, Brinkman N, Gentinetta T, Edler M, Petrillo S, Tolosano E, Miescher S, Le Jeune S, Houillier P, Chauvet S, Rabant M, Dimitrov JD, Fremeaux-Bacchi V, Blanc-Brude OP, Roumenina LT.

JCI Insight. 2018 Jun 21;3(12). pii: 96910. doi: 10.1172/jci.insight.96910. eCollection 2018 Jun 21.

11.

Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.

Merle NS, Grunenwald A, Figueres ML, Chauvet S, Daugan M, Knockaert S, Robe-Rybkine T, Noe R, May O, Frimat M, Brinkman N, Gentinetta T, Miescher S, Houillier P, Legros V, Gonnet F, Blanc-Brude OP, Rabant M, Daniel R, Dimitrov JD, Roumenina LT.

Front Immunol. 2018 Mar 1;9:179. doi: 10.3389/fimmu.2018.00179. eCollection 2018.

12.

[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report].

Zaworski J, Frimat M, Duval M, Saint-Jacques C, Bouderlique É, Glowacki F, Noël C, Hazzan M, Provôt F.

Nephrol Ther. 2018 Apr;14(2):112-116. doi: 10.1016/j.nephro.2017.10.004. Epub 2017 Dec 30. French.

PMID:
29295766
13.

Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report.

Maanaoui M, Saint-Jacques C, Gnemmi V, Frimat M, Lionet A, Hazzan M, Noël C, Provot F.

Medicine (Baltimore). 2017 Jun;96(25):e7196. doi: 10.1097/MD.0000000000007196.

14.

[New scores in renal transplantation: How can we use them?]

Hazzan M, Frimat M, Glowacki F, Lionet A, Provot F, Noël C.

Nephrol Ther. 2017 Apr;13 Suppl 1:S131-S136. doi: 10.1016/j.nephro.2017.01.005. French.

PMID:
28577735
15.

Kidney, heart and brain: three organs targeted by ageing and glycation.

Frimat M, Daroux M, Litke R, Nevière R, Tessier FJ, Boulanger E.

Clin Sci (Lond). 2017 Jun 1;131(11):1069-1092. doi: 10.1042/CS20160823. Review.

PMID:
28515343
16.

Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.

Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J, Frimat M, Ulinski T, Deschênes G, Burtey S, Delahousse M, Moulin B, Legendre C, Frémeaux-Bacchi V, Le Quintrec M.

J Am Soc Nephrol. 2017 May;28(5):1603-1613. doi: 10.1681/ASN.2016030343. Epub 2017 Jan 17.

17.

In Reply to 'Risk of Tranexamic Acid for Treatment of Postpartum Hemorrhage'.

Frimat M, Provôt F, Hertig A.

Am J Kidney Dis. 2017 Jan;69(1):160-161. doi: 10.1053/j.ajkd.2016.10.011. No abstract available.

PMID:
28007188
18.

Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after.

Tabibzadeh N, Glowacki F, Frimat M, Elsermans V, Provôt F, Lionet A, Gnemmi V, Hertig A, Noël C, Hazzan M.

Clin Transplant. 2016 Nov;30(11):1480-1487. doi: 10.1111/ctr.12843. Epub 2016 Oct 13.

PMID:
27623348
19.

Endothelial cells: source, barrier, and target of defensive mediators.

Roumenina LT, Rayes J, Frimat M, Fremeaux-Bacchi V.

Immunol Rev. 2016 Nov;274(1):307-329. doi: 10.1111/imr.12479. Review.

PMID:
27782324
20.

Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.

Buob D, Decambron M, Gnemmi V, Frimat M, Hoffmann M, Azar R, Gheerbrant JD, Guincestre T, Noël C, Copin MC, Glowacki F.

Kidney Int. 2016 Dec;90(6):1321-1331. doi: 10.1016/j.kint.2016.07.021. Epub 2016 Sep 17.

PMID:
27650730
21.

Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series.

Frimat M, Decambron M, Lebas C, Moktefi A, Lemaitre L, Gnemmi V, Sautenet B, Glowacki F, Subtil D, Jourdain M, Rigouzzo A, Brocheriou I, Halimi JM, Rondeau E, Noel C, Provôt F, Hertig A.

Am J Kidney Dis. 2016 Jul;68(1):50-7. doi: 10.1053/j.ajkd.2015.11.022. Epub 2016 Jan 16.

PMID:
26786299
22.

FDG PET/CT allowing detection and follow-up of tumor cell transplantation.

Jaillard A, Baillet C, Béron A, Tabibzadeh N, Scherpereel A, Frimat M, Perbet R, Gnemmi V, Noël C, Huglo D.

Ann Nucl Med. 2016 Apr;30(3):250-4. doi: 10.1007/s12149-015-1051-x. Epub 2015 Dec 17.

PMID:
26681195
23.

Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients.

Bloch J, Hazzan M, Van der Hauwaert C, Buob D, Savary G, Hertig A, Gnemmi V, Frimat M, Perrais M, Copin MC, Broly F, Noël C, Pottier N, Cauffiez C, Glowacki F.

Pharmacogenomics. 2014 Dec;15(16):2011-24. doi: 10.2217/pgs.14.146.

PMID:
25521359
24.

Loss of DGKε induces endothelial cell activation and death independently of complement activation.

Bruneau S, Néel M, Roumenina LT, Frimat M, Laurent L, Frémeaux-Bacchi V, Fakhouri F.

Blood. 2015 Feb 5;125(6):1038-46. doi: 10.1182/blood-2014-06-579953. Epub 2014 Dec 10.

PMID:
25498910
25.

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

Frimat M, Tabarin F, Dimitrov JD, Poitou C, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT.

Blood. 2013 Jul 11;122(2):282-92. doi: 10.1182/blood-2013-03-489245. Epub 2013 May 21.

PMID:
23692858
26.

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V.

Blood. 2012 May 3;119(18):4182-91. doi: 10.1182/blood-2011-10-383281. Epub 2012 Jan 13.

27.

[Renal malakoplakia: an underestimate cause of renal failure].

Daroux M, Frimat M, Mirault T, Fleury D, Lemaitre V, Noel LH, Vanhille P.

Nephrol Ther. 2011 Apr;7(2):111-6. doi: 10.1016/j.nephro.2010.10.010. Epub 2010 Dec 3. French.

PMID:
21126934

Supplemental Content

Loading ...
Support Center